(IN BRIEF) SCHOTT Pharma’s Supervisory Board has prolonged CEO Andreas Reisse’s mandate until April 2026, reflecting his pivotal role in driving the company’s emergence as a world-leading manufacturer of pharmaceutical containment and delivery systems. CFO Dr. Almuth Steinkühler will step … Read the full press release →
Posted in Business, Financial, Germany, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Almuth Steinkühler, Andreas Reisse, appointment, capital market, CEO extension, CFO Transition, corporate finance, delivery systems, executive leadership, Frankfurt Stock Exchange, Getinge, Hansgrohe, industrial engineering, IPO readiness, ledership, Nilfisk, Peter Goldschmidt, pharmaceutical containment solutions, process digitisation, Reinhard Mayer, SCHOTT Pharma, Supervisory Board, sustainable growth